Medical News

RSS

CHCWM, Priority Health partner to explore oncology patient-centered medical home

In keeping with society's urgent need for more efficient and effective health care, Priority Health and Cancer and Hematology Centers of West Michigan (CHCWM) have joined forces to explore an innovative oncology patient-centered medical home.

19 Nov 2011

Viewpoints: Waiting for the super committee; TV coverage of Supreme Court's health law session

Congress's bipartisan super committee is heading toward its November 23 deadline with no deal in sight to cut $1.2 trillion from the deficit over 10 years. So it's time to think seriously about the consequences of the default alternative, which would be a $1.2 trillion "sequester," or automatic spending cut, starting in 2013. It's hardly the nightmare of Washington dread.

19 Nov 2011

Pfizer receives 2011 Business Civic Leadership Center's Corporate Citizenship Award

Pfizer Inc. today announced that it has received the 2011 Business Civic Leadership Center's Corporate Citizenship Award in the Best International Ambassador category for Pfizer's Global Health Partnerships program.

19 Nov 2011

FDA approves EYLEA for treatment of wet Age-related Macular Degeneration

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD) at a recommended dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 mg every eight weeks.

19 Nov 2011

Smile Brands announces opening of Bright Now! Dental office in Stockton, CA

Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its next Bright Now! Dental office in Stockton, CA – the 16th office in Northern California.

19 Nov 2011

Abbott receives FDA approval for new Chagas assay

The U.S. Food and Drug Administration today approved the first test for use as an additional, more specific test on human serum or plasma specimens found to be positive for antibodies to Trypanosoma cruzi.

19 Nov 2011

Senator Klein opens new Cognitive Neurophysiology Laboratory at Albert Einstein College of Medicine

New York State Senator Jeffrey D. Klein joined administrators and faculty members of Albert Einstein College of Medicine of Yeshiva University last Friday to officially open their new Cognitive Neurophysiology Laboratory.

19 Nov 2011

VA implements spouse telephone support program

The Department of Veterans Affairs is implementing a telephone support program to help the spouses of returning Iraq and Afghanistan Veterans, after a pilot telephone support program showed significant reduction in stress for spouses.

19 Nov 2011

Diabetes dashboard saves time, improves accuracy and enhances patient care

In the fast-paced world of health care, doctors are often pressed for time during patient visits. Researchers at the University of Missouri developed a tool that allows doctors to view electronic information about patients' health conditions related to diabetes on a single computer screen. A new study shows that this tool, the diabetes dashboard, saves time, improves accuracy and enhances patient care.

18 Nov 2011

VA to join National Family Caregivers Association

The Department of Veterans Affairs will join the National Family Caregivers Association to recognize and appreciate dedicated partners providing daily health care for Veterans during National Family Caregiver Month in November.

18 Nov 2011

Scientists identify novel gene mutation that causes glioblastoma

Scientists at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center, in collaboration with colleagues in Boston and South Korea, say they have identified a novel gene mutation that causes at least one form of glioblastoma (GBM), the most common type of malignant brain tumor.

18 Nov 2011

Merrimack initiates MM-121 Phase 2 combination trial in metastatic NSCLC

Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, in combination with erlotinib, a small molecule directed at the epidermal growth factor receptor (EGFR), in three groups of patients with metastatic non-small cell lung cancer.

18 Nov 2011

NCQA to release standards and guidelines that compose new ACO Accreditation program

On November 21, the National Committee for Quality Assurance (NCQA) will release the standards and guidelines that compose its new Accountable Care Organization (ACO) Accreditation program.

18 Nov 2011

Deep brain stimulation benefits highly treatment resistant patients with major depressive disorder

Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.

18 Nov 2011